Book runners pumping to short shares to absorb the offering at a lower price. $150m worth will be a lot of shares for them to accumulate short. that's why the run up and squeeze.
Seems like co. desperate for money bc the results were interim of phase 2. maybe get a pricing below $30
Seems like co. desperate for money bc the results were interim of phase 2. maybe get a pricing below $30
Recent SRRK News
- Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference • Business Wire • 05/20/2026 12:00:00 PM
- Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 05/15/2026 08:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 11:15:38 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:10:21 AM
- Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights • Business Wire • 05/07/2026 11:00:00 AM
- Scholar Rock to Present at the BofA Securities 2026 Health Care Conference • Business Wire • 04/29/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/22/2026 09:20:45 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/22/2026 09:18:39 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/22/2026 09:16:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/20/2026 10:12:15 PM
- Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/17/2026 08:15:00 PM
- Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026 • Business Wire • 04/16/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/06/2026 08:11:20 PM
- Scholar Rock shares jump after FDA resubmission for SMA therapy • IH Market News • 03/31/2026 02:56:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 11:14:27 AM
- Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA) • Business Wire • 03/31/2026 11:00:00 AM
- Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/13/2026 08:15:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 03/03/2026 09:30:41 PM
- CORRECTING and REPLACING Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • Business Wire • 03/03/2026 08:26:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/03/2026 12:20:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/03/2026 12:16:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/03/2026 12:14:35 PM
- Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • Business Wire • 03/03/2026 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2026 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 09:30:14 PM
